Cargando…

Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units

BACKGROUND: In France, decisions to limit treatment fall under the Leonetti law adopted in 2005. Leading figures from the French world of politics, science, and justice recently claimed for amendments to the law, considering it incomplete. This study, conducted before any legislative change, aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesieur, Olivier, Leloup, Maxime, Gonzalez, Frédéric, Mamzer, Marie-France
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Paris 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486647/
https://www.ncbi.nlm.nih.gov/pubmed/26092498
http://dx.doi.org/10.1186/s13613-015-0056-x
_version_ 1782378907626897408
author Lesieur, Olivier
Leloup, Maxime
Gonzalez, Frédéric
Mamzer, Marie-France
author_facet Lesieur, Olivier
Leloup, Maxime
Gonzalez, Frédéric
Mamzer, Marie-France
author_sort Lesieur, Olivier
collection PubMed
description BACKGROUND: In France, decisions to limit treatment fall under the Leonetti law adopted in 2005. Leading figures from the French world of politics, science, and justice recently claimed for amendments to the law, considering it incomplete. This study, conducted before any legislative change, aimed to investigate the procedural aspects of withholding/withdrawing treatment in French ICUs and their adequacy with the existing law. METHODS: The characteristics of patients qualified for a withholding/withdrawal procedure were prospectively collected in 43 French ICUs. The study period (60 or 90 days under normal operating conditions) took place in the first half of 2013. RESULTS: During the study period, 777 (14 %) of 5589 admitted patients and 584 (52 %) of 1132 patients dying in the ICU had their treatment withheld or withdrawn. Whereas 344 patients had treatment(s) withheld (i.e., not started or not increased if already engaged), 433 had one or more treatment(s) withdrawn. Withdrawal of treatment was applied in 156 of 223 (70 %) brain-injured patients, compared to 277 of 554 (50 %) patients with other reasons for admission (p < 0.01). At the time of the decision-making, the patient’s wishes were known in 181 (23 %) of the 777 cases in one or more different way(s): 73 (9.4 %) from the patient, 10 (1.3 %) by advance directives, 10 (1.3 %) through a designated trusted person, and 108 (13.9 %) reported by the family or close relatives. An external consultant was involved in less than half of all decisions (356 of 777, 46 %). Of the 777 patients qualified for a withholding/withdrawal procedure, 133 (17 %) were discharged alive from the hospital (126 after withholding, 7 after withdrawal). CONCLUSIONS: More than half of deaths in the study population occurred after a decision to withhold or withdraw treatment. Among patients under withholding/withdrawal procedures, brain-injured subjects were more likely to undergo a withdrawal procedure. The prevalence of advance directives and designated trusted persons was low. Because patients’ preferences were unknown in more than three quarters of cases, decisions remained primarily based on medical judgment. Limitations, especially withholding of treatment, did not preclude survival and hospital discharge.
format Online
Article
Text
id pubmed-4486647
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Paris
record_format MEDLINE/PubMed
spelling pubmed-44866472015-07-07 Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units Lesieur, Olivier Leloup, Maxime Gonzalez, Frédéric Mamzer, Marie-France Ann Intensive Care Research BACKGROUND: In France, decisions to limit treatment fall under the Leonetti law adopted in 2005. Leading figures from the French world of politics, science, and justice recently claimed for amendments to the law, considering it incomplete. This study, conducted before any legislative change, aimed to investigate the procedural aspects of withholding/withdrawing treatment in French ICUs and their adequacy with the existing law. METHODS: The characteristics of patients qualified for a withholding/withdrawal procedure were prospectively collected in 43 French ICUs. The study period (60 or 90 days under normal operating conditions) took place in the first half of 2013. RESULTS: During the study period, 777 (14 %) of 5589 admitted patients and 584 (52 %) of 1132 patients dying in the ICU had their treatment withheld or withdrawn. Whereas 344 patients had treatment(s) withheld (i.e., not started or not increased if already engaged), 433 had one or more treatment(s) withdrawn. Withdrawal of treatment was applied in 156 of 223 (70 %) brain-injured patients, compared to 277 of 554 (50 %) patients with other reasons for admission (p < 0.01). At the time of the decision-making, the patient’s wishes were known in 181 (23 %) of the 777 cases in one or more different way(s): 73 (9.4 %) from the patient, 10 (1.3 %) by advance directives, 10 (1.3 %) through a designated trusted person, and 108 (13.9 %) reported by the family or close relatives. An external consultant was involved in less than half of all decisions (356 of 777, 46 %). Of the 777 patients qualified for a withholding/withdrawal procedure, 133 (17 %) were discharged alive from the hospital (126 after withholding, 7 after withdrawal). CONCLUSIONS: More than half of deaths in the study population occurred after a decision to withhold or withdraw treatment. Among patients under withholding/withdrawal procedures, brain-injured subjects were more likely to undergo a withdrawal procedure. The prevalence of advance directives and designated trusted persons was low. Because patients’ preferences were unknown in more than three quarters of cases, decisions remained primarily based on medical judgment. Limitations, especially withholding of treatment, did not preclude survival and hospital discharge. Springer Paris 2015-06-19 /pmc/articles/PMC4486647/ /pubmed/26092498 http://dx.doi.org/10.1186/s13613-015-0056-x Text en © Lesieur et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Lesieur, Olivier
Leloup, Maxime
Gonzalez, Frédéric
Mamzer, Marie-France
Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units
title Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units
title_full Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units
title_fullStr Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units
title_full_unstemmed Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units
title_short Withholding or withdrawal of treatment under French rules: a study performed in 43 intensive care units
title_sort withholding or withdrawal of treatment under french rules: a study performed in 43 intensive care units
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486647/
https://www.ncbi.nlm.nih.gov/pubmed/26092498
http://dx.doi.org/10.1186/s13613-015-0056-x
work_keys_str_mv AT lesieurolivier withholdingorwithdrawaloftreatmentunderfrenchrulesastudyperformedin43intensivecareunits
AT leloupmaxime withholdingorwithdrawaloftreatmentunderfrenchrulesastudyperformedin43intensivecareunits
AT gonzalezfrederic withholdingorwithdrawaloftreatmentunderfrenchrulesastudyperformedin43intensivecareunits
AT mamzermariefrance withholdingorwithdrawaloftreatmentunderfrenchrulesastudyperformedin43intensivecareunits
AT withholdingorwithdrawaloftreatmentunderfrenchrulesastudyperformedin43intensivecareunits